Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Inflammatory Bowel Disease in Mice

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2017 Jun 8

PMID 28589143

Citations 121

Authors

Fei Mao

Yunbing Wu

Xudong Tang

Jingjing Kang

Bin Zhang

Yongmin Yan

Hui Qian

Xu Zhang

Wenrong Xu

Affiliations

Soon will be listed here.

Abstract

Exosomes secreted by mesenchymal stem cells (MSCs) have shown repairing effects on several tissue injury diseases. In this study, we aimed to investigate the effects of exosomes released from human umbilical cord mesenchymal stem cells (hucMSCs) on the treatment of dextran sulfate sodium- (DSS-) induced inflammatory bowel disease (IBD) and to explore the underlying mechanism. We found that indocyanine green (ICG) labeled exosomes homed to colon tissues of IBD mice at 12 hours after injection. Exosomes significantly relieved the severity of IBD in mice as hucMSCs. The expression of IL-10 gene was increased while that of TNF-, IL-1, IL-6, iNOS, and IL-7 genes was decreased in the colon tissues and spleens of exosomes-treated mice. Furthermore, the infiltration of macrophages into the colon tissues was decreased by exosome treatment in IBD mice. In addition, we provided evidence that in vitro coculture with exosomes inhibited the expression of iNOS and IL-7 in mouse enterocoelia macrophages. Moreover, we found that the expression of IL-7 was higher in the colon tissues of colitis patients than that of healthy controls. Our findings suggest that exosomes from hucMSCs have profound effects on alleviating DSS-induced IBD and may exert their impact through the modulation of IL-7 expression in macrophages.

Citing Articles

Perianal fistulizing Crohn's disease: Mechanisms and treatment options focusing on cellular therapy.

Bhatnagar P, Elhariri S, Burud I, Eid N World J Gastroenterol. 2025; 31(9):100221.

PMID: 40061590 PMC: 11886048. DOI: 10.3748/wjg.v31.i9.100221.

Amniotic epithelial Cell microvesicles uptake inhibits PBMCs and Jurkat cells activation by inducing mitochondria-dependent apoptosis.

Cervero-Varona A, Prencipe G, Peserico A, Canciello A, House A, Santos H iScience. 2025; 28(2):111830.

PMID: 39967871 PMC: 11834128. DOI: 10.1016/j.isci.2025.111830.

Efficacy of umbilical cord-derived mesenchymal stem cells and exosomes in conjunction with standard IBD drug on immune responses in an IBD mouse model.

Kheradmand F, Yasaman Rahimzadeh S, Esmaeili S, Negah S, Farkhad N, Nazari S Stem Cell Res Ther. 2025; 16(1):5.

PMID: 39773498 PMC: 11707839. DOI: 10.1186/s13287-024-04062-y.

Exosome-based therapies for inflammatory disorders: a review of recent advances.

Saleem M, Shahzad K, Marryum M, Singh S, Zhou Q, Du S Stem Cell Res Ther. 2024; 15(1):477.

PMID: 39695750 PMC: 11657721. DOI: 10.1186/s13287-024-04107-2.

Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy.

Njoku G, Forkan C, Soltysik F, Nejsum P, Pociot F, Yarani R Bioact Mater. 2024; 45:41-57.

PMID: 39610953 PMC: 11602541. DOI: 10.1016/j.bioactmat.2024.11.004.

References

Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q . Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int. 2007; 32(1):8-15. DOI: 10.1016/j.cellbi.2007.08.002. View

Zhang B, Shen L, Shi H, Pan Z, Wu L, Yan Y . Exosomes from Human Umbilical Cord Mesenchymal Stem Cells: Identification, Purification, and Biological Characteristics. Stem Cells Int. 2017; 2016:1929536. PMC: 5220513. DOI: 10.1155/2016/1929536. View

Korolkova O, Myers J, Pellom S, Wang L, MKoma A . Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clin Med Insights Gastroenterol. 2015; 8:29-44. PMC: 4459555. DOI: 10.4137/CGast.S20612. View

Gatti S, Bruno S, Deregibus M, Sordi A, Cantaluppi V, Tetta C . Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 2011; 26(5):1474-83. DOI: 10.1093/ndt/gfr015. View

Nemoto Y, Kanai T, Takahara M, Oshima S, Nakamura T, Okamoto R . Bone marrow-mesenchymal stem cells are a major source of interleukin-7 and sustain colitis by forming the niche for colitogenic CD4 memory T cells. Gut. 2012; 62(8):1142-52. PMC: 3711361. DOI: 10.1136/gutjnl-2012-302029. View

Nagaishi K, Arimura Y, Fujimiya M . Stem cell therapy for inflammatory bowel disease. J Gastroenterol. 2015; 50(3):280-6. DOI: 10.1007/s00535-015-1040-9. View

Lai R, Arslan F, Lee M, Sze N, Choo A, Chen T . Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010; 4(3):214-22. DOI: 10.1016/j.scr.2009.12.003. View

Schorey J, Bhatnagar S . Exosome function: from tumor immunology to pathogen biology. Traffic. 2008; 9(6):871-81. PMC: 3636814. DOI: 10.1111/j.1600-0854.2008.00734.x. View

Bieback K, Netsch P . Isolation, Culture, and Characterization of Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells. Methods Mol Biol. 2016; 1416:245-58. DOI: 10.1007/978-1-4939-3584-0_14. View

10.

Breynaert C, Vermeire S, Rutgeerts P, Van Assche G . Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?. Acta Gastroenterol Belg. 2009; 71(4):367-72. View

11.

Pap E, Pallinger E, Pasztoi M, Falus A . Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res. 2009; 58(1):1-8. DOI: 10.1007/s00011-008-8210-7. View

12.

Uranga J, Lopez-Miranda V, Lombo F, Abalo R . Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease. Pharmacol Rep. 2016; 68(4):816-26. DOI: 10.1016/j.pharep.2016.05.002. View

13.

Andrews C, McLean M, Durum S . Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature. Inflamm Bowel Dis. 2016; 22(9):2255-64. PMC: 4992429. DOI: 10.1097/MIB.0000000000000818. View

14.

He H, Zhao Z, Han F, Liu X, Wang R, Zeng Y . Overexpression of protein kinase C ɛ improves retention and survival of transplanted mesenchymal stem cells in rat acute myocardial infarction. Cell Death Dis. 2016; 7:e2056. PMC: 4816190. DOI: 10.1038/cddis.2015.417. View

15.

Okamoto R, Watanabe M . Investigating cell therapy for inflammatory bowel disease. Expert Opin Biol Ther. 2016; 16(8):1015-23. DOI: 10.1080/14712598.2016.1177019. View

16.

Kappelman M, Rifas-Shiman S, Porter C, Ollendorf D, Sandler R, Galanko J . Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008; 135(6):1907-13. PMC: 2613430. DOI: 10.1053/j.gastro.2008.09.012. View

17.

Polchert D, Sobinsky J, Douglas G, Kidd M, Moadsiri A, Reina E . IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol. 2008; 38(6):1745-55. PMC: 3021120. DOI: 10.1002/eji.200738129. View

18.

Kim H, Choi D, Yun S, Choi S, Kang J, Jung J . Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res. 2011; 11(2):839-49. DOI: 10.1021/pr200682z. View

19.

Williams A, Hare J . Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011; 109(8):923-40. PMC: 3604746. DOI: 10.1161/CIRCRESAHA.111.243147. View

20.

Deans R, Moseley A . Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol. 2000; 28(8):875-84. DOI: 10.1016/s0301-472x(00)00482-3. View